Evidence map›Paper›PMID 38761068›Full record

ArticleJournal of the American Heart Association2024

Prognostic Impact of

Ju Hyeon Kim, Seung-Jun Lee, Jung-Joon Cha, Jae Hyoung Park, Soon Jun Hong, Tae Hoon Ahn, Byeong-Keuk Kim, Kiyuk Chang, Yongwhi Park, Young Bin Song and 11 more

Registry-linked trialAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04734028 (Platelet Function and genoType-Related Long-term progGosis in DES-treated Patients), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04734028 completednot on this map

Platelet Function and genoType-Related Long-term progGosis in DES-treated Patients : A Consortium From Multi-centered Registries

TypeobservationalSponsorGyeongsang National University HospitalRan2003 to 2020Enrolled13,160ConditionsCoronary Artery Disease, Clopidogrel, Poor Metabolism of, Platelet Dysfunction, Stent ThrombosisArmsClopidogrel Tablets
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Ju Hyeon KimDepartment of Cardiology, Cardiovascular Center Korea University Anam Hospital, Korea University College of Medicine Seoul South Korea.ORCID 0000-0002-4193-0891
Seung-Jun LeeSeverance Cardiovascular Hospital Seoul South Korea.ORCID 0000-0002-9201-4818
Jung-Joon ChaDepartment of Cardiology, Cardiovascular Center Korea University Anam Hospital, Korea University College of Medicine Seoul South Korea.ORCID 0000-0002-8299-1877
Jae Hyoung ParkDepartment of Cardiology, Cardiovascular Center Korea University Anam Hospital, Korea University College of Medicine Seoul South Korea.ORCID 0000-0001-8434-0157
Soon Jun HongDepartment of Cardiology, Cardiovascular Center Korea University Anam Hospital, Korea University College of Medicine Seoul South Korea.ORCID 0000-0003-4832-6678
Tae Hoon AhnDepartment of Cardiology Heart and Brain Institute, Chung-Ang University Gwang-Myeong Hospital, Chung-Ang University College of Medicine Gwangmyeong-si South Korea.ORCID 0000-0003-1544-1784
Byeong-Keuk KimSeverance Cardiovascular Hospital Seoul South Korea.ORCID 0000-0003-2493-066X
Kiyuk ChangDivision of Cardiology, Department of Internal Medicine College of Medicine, Catholic University of Korea Seoul South Korea.ORCID 0000-0003-3456-8705
Yongwhi ParkDepartment of Internal Medicine Gyeongsang National University School of Medicine and Cardiovascular Center, Gyeongsang National University Changwon Hospital Changwon South Korea.ORCID 0000-0003-3626-9717
Young Bin SongDivision of Cardiology, Department of Medicine, Samsung Medical Center Sungkyunkwan University School of Medicine Seoul South Korea.ORCID 0000-0003-3986-9152
Sung Gyun AhnDepartment of Cardiology Yonsei University Wonju Severance Christian Hospital Wonju South Korea.ORCID 0000-0002-1528-2739
Jung-Won SuhDepartment of Cardiology, Department of Internal Medicine Seoul National University Bundang Hospital, Seoul National University College of Medicine Seoul South Korea.ORCID 0000-0002-0397-6071
Sang Yeub LeeDepartment of Cardiology Heart and Brain Institute, Chung-Ang University Gwang-Myeong Hospital, Chung-Ang University College of Medicine Gwangmyeong-si South Korea.ORCID 0000-0003-1386-349X
Jung Rae ChoCardiology Division, Department of Internal Medicine, Kangnam Sacred Heart Hospital Hallym University College of Medicine Seoul South Korea.ORCID 0000-0002-9803-6612
Ae-Young HerDivision of Cardiology, Department of Internal Medicine Kangwon National University School of Medicine Chuncheon South Korea.ORCID 0000-0002-9990-6843
Young-Hoon JeongDepartment of Cardiology Heart and Brain Institute, Chung-Ang University Gwang-Myeong Hospital, Chung-Ang University College of Medicine Gwangmyeong-si South Korea.ORCID 0000-0003-0403-3726
Hyo-Soo KimCardiovascular Center, Department of Internal Medicine Seoul National University Hospital Seoul South Korea.ORCID 0000-0003-0847-5329
Moo Hyun KimDepartment of Cardiology Dong-A University Hospital Busan South Korea.ORCID 0000-0003-3468-6453
Eun-Seok ShinDivision of Cardiology Ulsan University Hospital, University of Ulsan College of Medicine Ulsan South Korea.ORCID 0000-0002-9169-6968
Do-Sun LimDepartment of Cardiology, Cardiovascular Center Korea University Anam Hospital, Korea University College of Medicine Seoul South Korea.ORCID 0000-0001-5751-5177
PTRG‐DES Consortium Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCarriers of METHODS AND

resultsThe study included 1201 older patients (aged ≥75 years) who underwent percutaneous coronary intervention and received clopidogrel-based dual antiplatelet therapy in South Korea. Patients were grouped on the basis of

conclusionsIn older patients, the presence of any REGISTRATION: URL: https://clinicaltrials.gov. Identifier: NCT04734028.

Indexed as

ClopidogrelCytochrome P-450 CYP2C19GenotypePercutaneous Coronary InterventionPlatelet Aggregation InhibitorsAgedAged, 80 and overAge FactorsCoronary Artery DiseaseDual Anti-Platelet TherapyFemaleHumansMaleMyocardial InfarctionPharmacogenomic VariantsPrognosisClopidogrelCYP2C19 protein, humanCytochrome P-450 CYP2C19Platelet Aggregation Inhibitorsagedcytochrome P‐450 2C19geneticsgenotypepercutaneous coronary interventionpolymorphism

Identifiers

PMID38761068
PMCPMC11179831

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.